Flucelvax Quadrivalent (2021/2022)

Manufacturer:

Seqirus

Name:

Flucelvax Quadrivalent (2021/2022)

HCPCS Code Descriptor:

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use

Category:

CPT Drug Code

HCPCS:

90756

NDC(s):

70461-0422-10

Primary Type:

Vaccine-Flu

Generic Status:

Single-Source

Route of Administration:

Intramuscular

About:

Flucelvax Quadrivalent (2021/2022) is a Vaccine-Flu drug manufactured by Seqirus and administered via the Intramuscular route of administration. The CPT Drug Code: 90756 is aligned to the drug Flucelvax Quadrivalent (2021/2022).